Nationally Recognized Firm Urges Zynex Investors to Explore Class Action Representation
NYC Today
Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, has filed a class action lawsuit against Zynex, Inc. (OTCMKTS: ZYXIQ) and certain of its officers. The lawsuit alleges that Zynex made materially false and/or misleading statements and failed to disclose material adverse facts about the company's business, operations, and prospects during the class period of February 25, 2021 to December 15, 2025.
The lawsuit claims that Zynex shipped products, including electrodes, in excess of need, inflating its revenue, and that the company's practice of filing false claims drew scrutiny from insurers like Tricare. The lawsuit also alleges that Zynex prioritized aggressive sales strategies over compliance with industry laws, rules and regulations, and that the company's order growth was a result of illegal overbilling, exposing it to potential adverse consequences.
The Complaint alleges that Zynex failed to disclose to investors that: (1) the company shipped products, including electrodes, in excess of need, inflating its revenue; (2) Zynex's practice of filing false claims drew scrutiny from insurers, including Tricare; (3) on August 21, 2023, Travelers commenced an action against Zynex, Sandgaard, Lucsok and Fox in the Superior Court of California alleging that Zynex and the defendants had embarked on a fraudulent...
WASHINGTON, April 23 (Reuters) – President Donald Trump’s years-long campaign to undermine faith in U.S. elections has gained broad traction with the American public, a Reuters/Ipsos poll shows, p...